Ulcerative Colitis Global Clinical Trials Review, H2, 2016

Introduction

Ulcerative Colitis Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, H2, 2016" provides an overview of Ulcerative Colitis clinical trials scenario. This report provides top line data relating to the clinical trials on Ulcerative Colitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Ulcerative Colitis Global Clinical Trials Review, H2, 2016

• Table of Contents

  Table of Contents 2

  List of Tables 3

  List of Figures 4

  Report Guidance 5

  Clinical Trials by Region 6

  Clinical Trials and Average Enrollment by Country 7

  Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9

  Top Five Countries Contributing to Clinical Trials in Europe 10

  Top Countries Contributing to Clinical Trials in North America 11

  Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12

  Top Five Countries Contributing to Clinical Trials in Central and South America 13

  Clinical Trials by G7 Countries: Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials 14

  Clinical Trials by Phase in G7 Countries 15

  Clinical Trials in G7 Countries by Trial Status 16

  Clinical Trials by E7 Countries: Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials 17

  Clinical Trials by Phase in E7 Countries 18

  Clinical Trials in E7 Countries by Trial Status 19

  Clinical Trials by Phase 20

  In Progress Trials by Phase 21

  Clinical Trials by Trial Status 22

  Clinical Trials by End Point Status 23

  Subjects Recruited Over a Period of Time 24

  Clinical Trials by Sponsor Type 25

  Prominent Sponsors 26

  Top Companies Participating in Ulcerative Colitis Therapeutics Clinical Trials 27

  Prominent Drugs 29

  Latest Clinical Trials News on Ulcerative Colitis 30

  Sep 21, 2016: Gilead Terminates Phase 2/3 Study of GS-5745 in Patients With Ulcerative Colitis 30

  Sep 16, 2016: Favorable Benefit: Risk Profile for Vedolizumab as Induction and Maintenance Therapy in TNF-Naïve or TNF-Failure Patients with Moderately to Severely Active Ulcerative Colitis Published in Clinical Gastroenterology and Hepatology 30

  Aug 22, 2016: Lycera Announces Initiation of Phase 2 Clinical Trial of LYC-30937-EC in Patients with Ulcerative Colitis 31

  Jul 28, 2016: Pfizer Announces Positive Top-Line Results from Pivotal Phase 3 Maintenance Trial of Oral XELJANZ (Tofacitinib Citrate) in Ulcerative Colitis 32

  Jul 13, 2016: InDex Pharmaceuticals publishes results from COLLECT study 33

  Clinical Trial Profile Snapshots 34

  Appendix 494

  Abbreviations 494

  Definitions 494

  Research Methodology 495

  Secondary Research 495

  About GlobalData 496

  Contact Us 496

  Disclaimer 496

  Source 497

List Of Tables
in Ulcerative Colitis Global Clinical Trials Review, H2, 2016

List of Tables

Ulcerative Colitis Therapeutics, Global, Clinical Trials by Region, 2016* 6

Ulcerative Colitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Ulcerative Colitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9

Ulcerative Colitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10

Ulcerative Colitis Therapeutics Clinical Trials, North America, Top Countries, 2016* 11

Ulcerative Colitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12

Ulcerative Colitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13

Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 14

Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15

Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16

Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 17

Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18

Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19

Ulcerative Colitis Therapeutics, Global, Clinical Trials by Phase, 2016* 20

Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21

Ulcerative Colitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22

Ulcerative Colitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23

Ulcerative Colitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24

Ulcerative Colitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25

Ulcerative Colitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26

Ulcerative Colitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28

Ulcerative Colitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List Of Figures, Charts and Diagrams
in Ulcerative Colitis Global Clinical Trials Review, H2, 2016

List of Figures

Ulcerative Colitis Therapeutics, Global, Clinical Trials by Region (%), 2016* 6

Ulcerative Colitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Ulcerative Colitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9

Ulcerative Colitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10

Ulcerative Colitis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11

Ulcerative Colitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12

Ulcerative Colitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13

Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 14

Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15

Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16

Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 17

Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18

Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19

Ulcerative Colitis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20

Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21

Ulcerative Colitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22

Ulcerative Colitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23

Ulcerative Colitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24

Ulcerative Colitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25

Ulcerative Colitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26

Ulcerative Colitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27

Ulcerative Colitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

GlobalData Methodology 495

Additional Details

Publisher

Global Data

Publisher Information

Reference

27440 | GDHC3742CTIDB

Number of Pages

497

Report Format

PDF

Related Reports